How does being vaccinated impact the risk of #LongCovid?
A thread on 8 studies (I'll add to it as I find more):
1/
The summary: vaccination definitely seems to reduce the risk of #LongCovid, often by 40-50%.
*But* solidly 9.5%-14% of breakthroughs still result in Long Covid.
These figures make sense to me, given the estimated rate of LC in unvaccinated people (~10-30%).
2/
A caveat: many of these studied people who had been vaccinated relatively recently, so as always, we can expect these findings to change a bit as immunity wanes.
3/
Study 1: this is one of two studies rated as high quality by UKHSA.
10,024 breakthrough cases with matched controls, looking 6 months from onset, found vaccination:
-did not reduce overall #LongCovid risk, but did reduce risk of some key symptoms: fatigue, anosmia, hair loss, lung disease, myalgia
-did not reduce risk for other symptoms: abdominal pain, headache
-did reduce severe outcomes (hospitalization, death, respiratory failure)
5/
Study 2: also rated high quality, this found a 7-10x reduced rate of #LongCovid!
Why the difference between Study 1? Not clear, but the number of breakthroughs was smaller (2400) here; it was also pre-Delta, where Study 1 included some Delta cases.
Study 4: 16035 breakthroughs & 3.57 million controls. Found vaccination had specific impacts:
-Reduced risk in cardiovascular, coagulation, metabolic, pulmonary organ systems, & fatigue
-Not reduced in kidney, gastrointestinal, neurologic systems
App-based study, 2370 breakthroughs with matched controls found that *full* vaccination reduced #LongCovid symptoms by roughly half. Notably, one dose resulted in the same Long Covid prevalence as unvaccinated controls.
The next 2 are weird or less comprehensive for different reasons.
11/
Study 7:
This one included a) uninfected controls & b) unvaccinated infected controls, along with vaccinated infected. Some false negatives or sick people were likely in the uninfected controls, because they had high baseline symptom rates (recruited from PCR test sites).
12/
Comparing unvaccinated to vaccinated, this study found some reductions in some symptoms, but not consistently across age groups.
-No reduction in loss of concentration, persistent cough, overall recovery
13/
-Did reduce fatigue, headache, weakness, myalgia, hair loss, dizziness & shortness of breath
-Most reductions higher in people >60 than age 19-35
-11% of vaccinated had fatigue vs 26% unvaccinated
-14% of vaccinated had headache vs 22% unvaccinated
In summary: get vaccinated to reduce your risk of #LongCovid, but be aware that if you get a breakthrough, the risk is still high!
16/
These findings might also suggest reductions in certain types of #LongCovid (respiratory and possibly cardiovascular stick out to me) but not to others (neurologic and gastrointestinal in particular).
17/
• • •
Missing some Tweet in this thread? You can try to
force a refresh
44 countries have experienced a 10-fold increase in at least 13 infectious diseases compared to pre-pandemic rates, including RSV, cholera, measles, influenza, chickenpox, tuberculosis (TB), and others. 2/
While some (like TB) may be related to declining vaccination rates, COVID impacts the others.
"Immune mechanisms [like] a period of increased vulnerability to other infections following acute COVID infection" is a major contributor, esp irt respiratory infections in children 3/
Michael Peluso (@MichaelPelusoMD) introduces CHIIME, which adds an arm of ME/CFS patients to the LIINC study - will include PET imaging and tissue biopsy analysis, gut biopsies:
Phenotyping with patient-reported and objective clinical measures:
Incredible visit Thursday to the opening of Mount Sinai’s Cohen Center for Recovery from Complex Chronic Illness, led by the renowned @PutrinoLab! #LongCovid 1/
The Center is incredible and truly blew me away - designed on so many levels with patients in mind, with top notch care, using many of the most advanced tools available 2/
Some of the many tools patients are assessed with include:
The fibrin also:
-promotes neuroinflammation & neuronal loss post infection
-promotes innate immune activation in the brain & lungs independent of active infection
-downregulated JAK-STAT pathway & targets of p38 MAP kinase, pathways that regulate NK cell activation #LongCovid 2/
They used a monoclonal antibody targeting the fibrin domain, and found it protected against microglial activation & neuronal injury, as well as from thromboinflammation in the lung after infection! #LongCovid 3/
I've been doing #TheNicotineTest (via 7mg patches) for a month now & it has greatly improved my quality of life.
Major caveat: I'm on ivabradine. The nicotine increases heart rate, & I wouldn't recommend to anyone w POTS who isn't on beta-blockers or ivabradine. #LongCovid 1/
The biggest change is feeling like I have more *oxygen* circulating in my body - the weird altitude-sickness feeling is lessened.
Major improvements to cognition/awareness (esp executive functioning & processing), and improved physical capacity and overall baseline. 2/
The first tolerance break I felt more air hunger and worse baseline than pre-nicotine, but every other tolerance break has been equal or better than pre-nicotine.
It feels like an excellent symptom management tool, but *not* a cure. 3/
This could cause additional impacts like deficits in platelet energy metabolism, or hormonal dysregulation (because platelets carry serotonin) #LongCovid